24
Participants
Start Date
March 31, 2008
Primary Completion Date
July 31, 2009
Study Completion Date
November 30, 2009
MKC-1
30 mg and 100 mg capsules, dosed BID daily on a continuous schedule
U. of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison
Lead Sponsor
CASI Pharmaceuticals, Inc.
INDUSTRY